Page 7 - Attribute Analysis News Today

ResearchAndMarkets.com’s offering. “Systemic lupus erythematosus (SLE): Disease Insights and Market Forecasts to 2026” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Systemic lupus erythematosus (SLE) disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Systemic lupus erythematosus (SLE), drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Global Non-Small Cell Lung Cancer (NSCLC) Disease Insights and Market Forecasts Report 2020-2026 - ResearchAndMarkets.com January 6, 2021 GMT DUBLIN--(BUSINESS WIRE)--Jan 6, 2021-- “Non-small cell lung cancer (NSCLC) : Disease Insights and Market Forecasts to 2026” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of NSCLC disease in the US, EU5 (Germany...

Share: ResearchAndMarkets.coms offering. "Systemic lupus erythematosus (SLE): Disease Insights and Market Forecasts to 2026" report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Systemic lupus erythematosus (SLE) disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Systemic lupus erythematosus (SLE), drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, ...

Press release content from Business Wire. The AP news staff was not involved in its creation. World Macular Oedema Disease Insights and Market Forecasts Report 2020-2026 - ResearchAndMarkets.com December 15, 2020 GMT DUBLIN--(BUSINESS WIRE)--Dec 15, 2020-- “Macular oedema: Disease Insights and Market Forecasts to 2026” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Macular oedema disease in the US, EU5 (Germany, France, Italy, Spain, UK), a...

Press release content from Business Wire. The AP news staff was not involved in its creation. Bladder Cancer Disease Insights and Market Forecasts Report 2020-2026 - ResearchAndMarkets.com December 15, 2020 GMT DUBLIN--(BUSINESS WIRE)--Dec 15, 2020-- “Bladder cancer: Disease Insights and Market Forecasts to 2026” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Bladder cancer disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Jap...

Disease Indication Overview: This section of the report gives the overview of Acne disease indication in detail. The section highlights the basic definition, causes and symptoms of disease and details the types of Acne disease. Further details on the profile of Acne patients, Symptoms experienced by the patients, and disease progression in patients are outlined in the report. The report further highlights the multiple methods through which the patient can be diagnosed for Acne disease. Epidemi...

Share: ResearchAndMarkets.coms offering. "Bladder cancer: Disease Insights and Market Forecasts to 2026" report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Bladder cancer disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Bladder cancer, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2026. D...

Disease Indication Overview: This section of the report gives the overview of Acne disease indication in detail. The section highlights the basic definition, causes and symptoms of disease and details the types of Acne disease. Further details on the profile of Acne patients, Symptoms experienced by the patients, and disease progression in patients are outlined in the report. The report further highlights the multiple methods through which the patient can be diagnosed for Acne disease. Epidemi...

Share: ResearchAndMarkets.coms offering. "Multiple myeloma: Disease Insights and Market Forecasts to 2026" report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Multiple myeloma disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Multiple myeloma, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2...

The  by DelveInsight analyses that the market will experience a boost due to the increase in the patient pool and launch of the emerging therapies such as Abilify, Lumateperone/ITI-007, NRX-100/NRX-101, Zuranolone, SEP-4199, and Falkieri during the forecast period. The  report offers insights on disease comprehension, historical and forecasted epidemiology; and Bipolar Depression market trends in the 7MM (United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). T...